A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus – clinical significance and possible mechanisms: a case report

Peer Review reports

Original Submission
30 Oct 2017	Submitted	Original manuscript
11 Nov 2017	Reviewed	Reviewer Report - Ahmet Emre Eskazan
16 Nov 2017	Reviewed	Reviewer Report - Alauldeen Zubair
13 Dec 2017	Author responded	Author comments - Nobuo Takemori
Resubmission - Version 2
13 Dec 2017	Submitted	Manuscript version 2
13 Dec 2017	Reviewed	Reviewer Report - Alauldeen Zubair
15 Dec 2017	Reviewed	Reviewer Report - Ahmet Emre Eskazan
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
21 Dec 2017	Editorially accepted
18 Feb 2018	Article published	10.1186/s13256-017-1550-6

Back to article page